Skip to main content
FinSpry Logo
FinSpry
ORMP logo
ORMP
(NASDAQ)
Oramed Pharmaceuticals Inc.
$3.42-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Oramed Pharmaceuticals (ORMP) Stock Price & Financial Analysis

Oramed Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$3.31 - $3.44
52-Week High$3.76
52-Week Low$1.82
Open$3.33
Volume42.94K
Average Volume (3M)42.94K
Market Cap146.29M
Shares Outstanding42.77M
P/E Ratio (TTM)3.31
Price to Sales (P/S)72.50
Price to Book (P/B)0.71
EV/EBITDA1.60
Revenue (TTM)2.00M
Net Income (TTM)43.85M
Free Cash Flow (TTM)-12.74M
EPS (TTM)$1.03
Profit Margin2192.60%
Operating Margin-650.55%
Return on Equity (ROE)21.57%
Debt to Equity0.00
50-Day MA$3.40
200-Day MA$2.69
52-Week Change59.15%
Annual Dividend$0.25
Dividend Yield7.37%
Payout Ratio24.39%
Last Dividend Ex-DateJan 16, 2026

Frequently Asked Questions About Oramed Pharmaceuticals

What is the current stock price for ORMP?

As of the latest trading session, ORMP stock trades at $3.42. The 52-week range is $1.82–$3.76, with a day range of $3.31–$3.44.

What is the P/E ratio for ORMP?

Oramed Pharmaceuticals's trailing P/E ratio is 3.3, meaning investors pay $3.3 for every $1 of annual earnings. Oramed Pharmaceuticals operates in the Healthcare sector.

Does ORMP pay dividends?

Yes, Oramed Pharmaceuticals pays a 7.37% annual dividend yield ($0.25 per share). The payout ratio is 24.4%. The last ex-dividend date was 2026-01-16.

What do analysts recommend for ORMP?

Analyst ratings and recommendations for ORMP are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of ORMP?

Oramed Pharmaceuticals's market capitalization is $146.3M, classifying it as a micro-cap company. Oramed Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.